Yongan Pharmaceutical: To use fossil oil or biomaterial, price decides

Summary: On Aug. 8, 2012, Qianjiang Yongan Pharmaceutical plans to invest USD3.14 million more on the technical betterment program of ethylene oxide, which can use both biological alcohol and fossil oil product—ethylene as feedstock based on th...

Biomaterials China News 201209

www.cnchemicals.com